Literature DB >> 32271376

Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).

Kaijin Xu1, Yanfei Chen1, Jing Yuan2, Ping Yi1, Cheng Ding1, Wenrui Wu1, Yongtao Li1, Qin Ni1, Rongrong Zou2, Xiaohe Li2, Min Xu1, Ying Zhang1, Hong Zhao1, Xuan Zhang1, Liang Yu1, Junwei Su1, Guanjing Lang1, Jun Liu1, Xiaoxin Wu1, Yongzheng Guo1, Jingjing Tao1, Ding Shi1, Ling Yu1, Qing Cao1, Bing Ruan1, Lei Liu2, Zhaoqin Wang2, Yan Xu1, Yingxia Liu2, Jifang Sheng1, Lanjuan Li1.   

Abstract

BACKGROUND: An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public health emergency. Data are limited on the duration and host factors related to viral shedding.
METHODS: In this retrospective study, risk factors associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA shedding were evaluated in a cohort of 113 symptomatic patients from 2 hospitals outside Wuhan.
RESULTS: The median (interquartile range) duration of SARS-CoV-2 RNA detection was 17 (13-22) days as measured from illness onset. When comparing patients with early (<15 days) and late (≥15 days after illness onset) viral RNA clearance, prolonged SARS-CoV-2 RNA shedding was associated with male sex (P = .009), old age (P = .033), concomitant hypertension (P = .009), delayed admission to hospital after illness onset (P = .001), severe illness at admission (P = .049), invasive mechanical ventilation (P = .006), and corticosteroid treatment (P = .025). Patients with longer SARS-CoV-2 RNA shedding duration had slower recovery of body temperature (P < .001) and focal absorption on radiograph images (P < .001) than patients with early SARS-CoV-2 RNA clearance. Male sex (OR, 3.24; 95% CI, 1.31-8.02), delayed hospital admission (OR, 1.30; 95% CI, 1.10-1.54), and invasive mechanical ventilation (OR, 9.88; 95% CI, 1.11-88.02) were independent risk factors for prolonged SARS-CoV-2 RNA shedding.
CONCLUSIONS: Male sex, delayed admission to hospital after illness onset, and invasive mechanical ventilation were associated with prolonged SARS-CoV-2 RNA shedding. Hospital admission and general treatments should be started as soon as possible in symptomatic COVID-19 patients, especially male patients.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-COV-2; coronavirus; risk factors; viral shedding

Mesh:

Substances:

Year:  2020        PMID: 32271376      PMCID: PMC7184421          DOI: 10.1093/cid/ciaa351

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  178 in total

1.  Case Report: Viral Shedding for 60 Days in a Woman with COVID-19.

Authors:  Junyao Li; Lin Zhang; Baihui Liu; Debiao Song
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

2.  Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-05-14       Impact factor: 8.262

3.  Clinical characteristics associated with long-term viral shedding in patients with coronavirus disease 2019.

Authors:  Miao Zhou; Fei-Fei Yu; Li Tan; Yu-Dan Zhu; Ning Ma; Li-Jun Song; Qi Li; Yang Liu; Zui Zou; Tian-Ying Xu; Chao Yu
Journal:  Am J Transl Res       Date:  2020-10-25       Impact factor: 4.060

Review 4.  Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications.

Authors:  Margarita V Revzin; Sarah Raza; Robin Warshawsky; Catherine D'Agostino; Neil C Srivastava; Anna S Bader; Ajay Malhotra; Ritesh D Patel; Kan Chen; Christopher Kyriakakos; John S Pellerito
Journal:  Radiographics       Date:  2020-10       Impact factor: 5.333

5. 

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

Review 6.  Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.

Authors:  Seyed Hamid Safiabadi Tali; Jason J LeBlanc; Zubi Sadiq; Oyejide Damilola Oyewunmi; Carolina Camargo; Bahareh Nikpour; Narges Armanfard; Selena M Sagan; Sana Jahanshahi-Anbuhi
Journal:  Clin Microbiol Rev       Date:  2021-05-12       Impact factor: 26.132

7.  COVID-19 and Speech-Language Pathology Clinical Practice of Voice and Upper Airway Disorders.

Authors:  Emerald J Doll; Maia N Braden; Susan L Thibeault
Journal:  Am J Speech Lang Pathol       Date:  2020-12-17       Impact factor: 2.408

8.  Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries.

Authors:  Marliana S Rejeki; Nana Sarnadi; Retno Wihastuti; Vininta Fazharyasti; Wisvici Y Samin; Frilasita A Yudhaputri; Edison Johar; Neni Nurainy; Novilia S Bachtiar; David H Muljono
Journal:  EClinicalMedicine       Date:  2021-06-04

9.  SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19.

Authors:  Grace Lai-Hung Wong; Terry Cheuk-Fung Yip; Vincent Wai-Sun Wong; Yee-Kit Tse; David Shu-Cheong Hui; Shui-Shan Lee; Eng-Kiong Yeoh; Henry Lik-Yuen Chan; Grace Chung-Yan Lui
Journal:  Open Forum Infect Dis       Date:  2021-04-23       Impact factor: 3.835

10.  Estimating COVID-19 recovery time in a cohort of Italian healthcare workers who underwent surveillance swab testing.

Authors:  R Benoni; I Campagna; S Panunzi; M S Varalta; G Salandini; G De Mattia; G Turrina; F Moretti; G Lo Cascio; G Spiteri; S Porru; S Tardivo; A Poli; C Bovo
Journal:  Public Health       Date:  2021-05-19       Impact factor: 2.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.